STAT January 19, 2025
AstraZeneca has forecast peak annual sales of the drug, to be marketed as Datroway, at more than $5 billion
A next-generation form of chemotherapy from AstraZeneca and Daiichi Sankyo has won Food and Drug Administration authorization for a form of breast cancer, the first U.S. approval for a drug for which...